Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Pulmonary Hypertension Due to Lung Diseases and Hypoxia clinical trials

3 of 3 indexed Pulmonary Hypertension Due to Lung Diseases and Hypoxia trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Pulmonary Hypertension Due to Lung Diseases and Hypoxia: 3 US clinical trials tracked, 3 recruiting.

Pulmonary Hypertension Due to Lung Diseases and Hypoxia is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of Kansas Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition pulmonary-hypertension-due-to-lung-diseases-and-hypoxia

OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Pulmonary Hypertension D (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Pulmonary Hypertension Due to Lung Diseases and Hypoxia lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pulmonary Hypertension Due to Lung Diseases and Hypoxia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pulmonary Hypertension Due to Lung Diseases and Hypoxia is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Pulmonary Hypertension Due to Lung Diseases and Hypoxia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Prospective study assessments Other
1 trials
Decrease in the PEEP followed by increase in the PEEP Other
1 trials
Increase in the PEEP followed by decrease in the PEEP Other
1 trials

US sites by state

Facility locations filed on Pulmonary Hypertension Due to Lung Diseases and Hypoxia trials. A trial with sites in several states counts in each.

Kansas 2 trials
Alabama 2 trials
New Jersey 1 trials
Missouri 1 trials
Maryland 1 trials
Louisiana 1 trials
Kentucky 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pulmonary Hypertension Due to Lung Diseases and Hypoxia page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Pulmonary Hypertension Due to Lung Diseases and Hypoxia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Kansas Medical Center sponsors the most Pulmonary Hypertension Due to Lung Diseases and Hypoxia trials on record, review their full trial history before evaluating a specific study. See University of Kansas Medical Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Hypertension Due to Lung Diseases and Hypoxia condition card totals 3 registered trials; most-linked intervention Prospective study assessments; top US site state Kansas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.